These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35059130)

  • 41. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
    Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats.
    Takeuchi K; Yagi K; Kato S; Ukawa H
    Gastroenterology; 1997 Nov; 113(5):1553-9. PubMed ID: 9352857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
    Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells.
    Takahashi S; Takeuchi K; Okabe S
    Biochem Pharmacol; 1999 Dec; 58(12):1997-2002. PubMed ID: 10591156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SC-46275: a potent and highly selective agonist at the EP3 receptor.
    Savage MA; Moummi C; Karabatsos PJ; Lanthorn TH
    Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):939-43. PubMed ID: 8140121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
    Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
    Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anaesthetized rats.
    Yokotani K; Okuma Y; Osumi Y
    Br J Pharmacol; 1996 Feb; 117(4):653-6. PubMed ID: 8646410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.
    Hassouneh R; Nasrallah R; Zimpelmann J; Gutsol A; Eckert D; Ghossein J; Burns KD; Hébert RL
    Diabetologia; 2016 Jun; 59(6):1318-28. PubMed ID: 26995650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EP3 activation facilitates bladder excitability via HCN channels on ICCs.
    Wu C; Dong X; Liu Q; Zhu J; Zhang T; Wang Q; Hu X; Yang Z; Li L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):535-541. PubMed ID: 28131828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic delivery of selective EP1 and EP3 receptor antagonists attenuates pentylenetetrazole-induced seizures in mice.
    Reschke CR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Lenz QF; Oliveira MS; Henshall DC; Mello CF
    Int J Physiol Pathophysiol Pharmacol; 2018; 10(1):47-59. PubMed ID: 29593850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors.
    Meisdalen K; Dajani OF; Christoffersen T; Sandnes D
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1044-50. PubMed ID: 17567965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.
    Brochhausen C; Neuland P; Kirkpatrick CJ; Nüsing RM; Klaus G
    Arthritis Res Ther; 2006; 8(3):R78. PubMed ID: 16646980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats.
    Rezq S; Abdel-Rahman AA
    J Pharmacol Exp Ther; 2016 Nov; 359(2):290-299. PubMed ID: 27572469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
    Molderings G; Malinowska B; Schlicker E
    Br J Pharmacol; 1992 Oct; 107(2):352-5. PubMed ID: 1330175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
    Negoro N; Sasaki S; Mikami S; Ito M; Suzuki M; Tsujihata Y; Ito R; Harada A; Takeuchi K; Suzuki N; Miyazaki J; Santou T; Odani T; Kanzaki N; Funami M; Tanaka T; Kogame A; Matsunaga S; Yasuma T; Momose Y
    ACS Med Chem Lett; 2010 Sep; 1(6):290-4. PubMed ID: 24900210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function.
    Tran PO; Gleason CE; Robertson RP
    Diabetes; 2002 Jun; 51(6):1772-8. PubMed ID: 12031964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.
    Kinoshita A; Higashino M; Aratani Y; Kakuuchi A; Matsuya H; Ohmoto K
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1016-1019. PubMed ID: 26725951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat.
    Kato S; Aihara E; Yoshii K; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G64-9. PubMed ID: 15961884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.